Profil
Jim Pepin currently works at Aimmune Therapeutics, Inc., as Senior Vice President & General Counsel and Legend Biotech Corp., as General Counsel from 2023.
Postes actifs de Jim Pepin
| Sociétés | Poste | Début |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Conseiller Juridique Général | - |
| LEGEND BIOTECH CORPORATION | Conseiller Juridique Général | 01/11/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
